There's no question that for patients coping with a rare or complex disease or a compromised immune system, COVID-19 resulted in multiple new...
Entering our third year of coping with a pandemic that continues to disrupt lives brings into ever sharper focus the multiple difficulties involved for...
While it may seem as if 30 million Americans living with more than 7,000 distinct and rare medical conditions have little in common, there is much that...
Maintaining, Monitoring, and Measuring a Smooth Patient Journey The journey of a rare disease patient is not an easy one from the start, frequently...
From filling out an insurance form to interpreting nutrition labels, a patient's understanding of what they're reading and ability to use that...
Mucopolysaccharidosis (MPS) is a rare disease in which the body is missing or does not have enough of an enzyme needed to break down long chains of...
This past year has shone a harsh light on some of our healthcare system’s most glaring flaws, illuminating a divide too deep to be ignored. Limited...
This blog was written by Mike Fieri, Orsini Founder and CEO. Of the numerous, notable medical breakthroughs in the last decade, few have elicited more...
Orsini is a leading independent national specialty pharmacy accredited by ACHC, JCAHO, URAC, and VIPPS. The services we provide allow patients, physicians, payors, and manufacturers to improve care, simplify processes, and achieve better outcomes.
Orsini Specialty Pharmacy Selected by Provention Bio as a Limited Distribution Partner for TZIELD
Choosing a Specialty Pharmacy to Support Mucopolysaccharidosis (MPS) Patients
Orsini Salutes Healthcare Quality Week
Six Ways Orsini Ensures No Patient is Left Behind
Choosing a Specialty Pharmacy to Support Patients with X-linked hypophosphatemia
.jpg?width=1754&name=SP_Logo_Color_RGB%202020update%20(1).jpg "Orsini Specialty Pharmacy Logo"){kind=logo}